Philadelphia‐chromosome positive thrombocythemia in a child
Pravas Mishra, M. Mahapatra, Rajat Kumar, Ashish Dixit, Tathagat Chatterjee, Seema Tyagi, Dharma R. Choudhry, Sudha Sazawal, V. P. Choudhry
Abstract
Pravas Mishra, M. Mahapatra, Rajat Kumar, Ashish Dixit, Tathagat Chatterjee, Seema Tyagi, Dharma R. Choudhry, Sudha Sazawal, V. P. Choudhry
Abstract
Philadelphia-chromosome positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood has been described in adults. It is rare in children. We present a case of Philadelphia positive thrombocythemia in a child who was managed with a combination of imatinib and hydroxyurea. Although a reduction in the BCR-ABL transcript was documented, the thrombocytosis was refractory to imatinib alone and required the addition of hydroxyurea.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Philadelphia-chromosome positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood has been described in adults. It is rare in children. We present a case of Philadelphia positive thrombocythemia in a child who was managed with a combination of imatinib and hydroxyurea. Although a reduction in the BCR-ABL transcript was documented, the thrombocytosis was refractory to imatinib alone and required the addition of hydroxyurea.
Key concepts: Essential thrombocythemia, Thrombocytosis, Imatinib, Medicine, Philadelphia chromosome, Myeloid leukemia, Anagrelide, Polycythemia vera